The Discounted Cash Flow (DCF) valuation of Rohto Pharmaceutical Co Ltd (4527.T) is 1,932.51 JPY. With the latest stock price at 2,068.00 JPY, the upside of Rohto Pharmaceutical Co Ltd based on DCF is -6.6%.
Based on the latest price of 2,068.00 JPY and our DCF valuation, Rohto Pharmaceutical Co Ltd (4527.T) is a sell. selling 4527.T stocks now will result in a potential gain of 6.6%.
| Range | Selected | |
| WACC / Discount Rate | 4.8% - 6.8% | 5.8% |
| Long-term Growth Rate | 1.0% - 3.0% | 2.0% |
| Fair Price | 1,346.38 - 3,819.82 | 1,932.51 |
| Upside | -34.9% - 84.7% | -6.6% |